![]() |
市场调查报告书
商品编码
1830977
光疗市场Light Therapy Market |
光疗市场预计将从 2024 年的 10.3 亿美元成长到 2031 年的 15.1 亿美元,2025 年至 2031 年期间的预估复合年增长率为 5.6%。
市场洞察与分析师观点:光疗法,通常称为光疗,是指利用特定波长的光来治疗各种疾病,包括皮肤病、情绪相关问题和睡眠障碍。这种非侵入性治疗方法利用光线的独特特性来激发体内的生物反应,主要针对皮肤或视网膜,同时也影响昼夜节律和情绪调节系统。光疗法有多种形式,例如用于治疗痤疮的蓝光疗法、用于嫩肤的红光疗法以及用于治疗季节性情感障碍的亮光疗法。
成长动力与挑战:蓝光疗法在皮肤病治疗的应用日益广泛,已成为推动光疗市场成长与多元化的关键因素。蓝光疗法是一种非侵入性光疗技术,在治疗痤疮、牛皮癣、湿疹和光化性角化病等各种皮肤病方面的应用日益广泛。其在治疗寻常性痤疮等特定皮肤问题方面的有效性,已引起医疗保健专业人士和寻求非药物治疗方案的个人的广泛关注和认可。技术进步进一步增强了蓝光疗法的应用,催生了具有优化蓝光波长的专用光传输系统的诞生,该系统可专门针对并缓解皮肤病的根本原因。家用蓝光治疗设备的普及也促进了市场的成长,使人们能够透过用户友好的解决方案便捷地管理皮肤问题。
相反,儘管光疗法具有许多治疗优势,但某些疗法可能产生的副作用已成为光疗法市场整体扩张的挑战。对皮肤刺激、眼睛疲劳和昼夜节律紊乱等潜在副作用的担忧,已引起医疗保健提供者和潜在用户的谨慎。这些担忧可能会阻碍人们考虑光疗法,尤其是在缺乏安全和正确使用资讯或指导的情况下。此外,精确剂量测定和严格遵守治疗方案的必要性,以及敏感族群出现不良反应的风险,都阻碍了光疗法的广泛接受。透过持续的研究、教育和改进的安全措施来应对这些风险,对于克服这些挑战并增强人们对光疗法安全性和有效性的信心至关重要,从而促进其更广泛的应用并促进市场成长。
策略洞察报告细分和范围:光疗市场根据类型、光源类型、应用和最终用户进行分类。根据类型,市场分为桌上型和便携式两类。光疗市场按光源类型细分为红光、蓝光和白光。在应用方面,市场分为精神健康障碍、皮肤病、新生儿黄疸等。关于最终用户,市场分为医院和专科诊所、家庭护理和其他。从地理上讲,光疗市场细分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、义大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳洲、韩国和亚太其他地区)、中东和非洲(阿联酋、沙乌地阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
細項分析:就类型而言,预计便携式光疗市场在2022年至2030年间的复合年增长率最高。便携式光疗设备改变了光疗的可及性和便利性,使人们即使在移动中也能获得治疗效果。这些便携式解决方案包括各种设备,例如紧凑型灯箱、可穿戴式遮光罩和手持式光棒,旨在在不同环境中提供有针对性的光疗。这些设备的便携性使用户可以轻鬆地将光疗融入日常生活,无论是在家中、办公室还是在旅途中。因此,便携式光疗扩大了光疗的覆盖范围,使人们能够更好地控制自己的健康习惯,并提高对处方光疗方案的依从性。
就光类型而言,光疗市场分为红光、蓝光和白光。红光疗法有望在未来几年获得显着发展,因为它能够透过促进细胞内的生化反应来增强粒线体功能。这会导致三磷酸腺苷 (ATP) 的产生增加,据称 ATP 可以促进头髮生长、促进伤口癒合、修復组织并逆转阳光损伤。
根据应用,光疗市场可细分为精神健康障碍、皮肤病、新生儿护理等。 2022年,医院皮肤病领域占据市场主导地位,预计在预测期内将实现显着的复合年增长率。光疗在治疗痤疮、牛皮癣、湿疹和皮肤炎等皮肤疾病方面的有效性,使其在医疗保健专业人员和寻求非药物治疗的个人中得到广泛应用。随着特定光波长对皮肤细胞及相关生物过程的光生物调节作用研究的不断深入,该领域经历了显着增长。
区域分析:从地理上看,光疗市场分为北美、欧洲、亚太、中东和非洲以及南美和中美。
北美是该市场成长的最大贡献者,这得益于牛皮癣和季节性情绪失调/冬季忧郁症(SAD/Winter blues)症状的日益增长;2022年,北美引领了全球光疗市场。在医疗监督下,光疗是指将皮肤暴露于人工光源的紫外线下。 UVB和UVA光,或两者结合,可用于缓解症状、消炎和控制皮肤细胞增殖。加拿大皮肤病学会估计,加拿大有100万人患有牛皮癣,这大大推动了对光疗设备的需求。预计亚太地区光疗市场将在2022年至2030年间录得最快的复合年增长率,这得益于远距医疗的大量投资以及人们对光疗益处日益增长的认识。
光疗市场报告范围产业发展与未来机会:全球光疗市场主要参与者采取的几项措施重点介绍如下:
2023年9月,知名护肤和美容技术提供者AMIRO推出了两款年度最具创新性的产品-AMIRO S2 SEAL紧肤仪和AMIRO LumoMax LED光疗脸部美容仪。 2022年6月,BioPhotas公司与Ulta Beauty建立合作关係。此次合作将利用Celluma PRO和Celluma ELITE两款产品,预计将满足美国55个不同地区顾客的护肤需求。这些产品已获得美国食品药物管理局(FDA)批准,可用于治疗各种疾病,包括皱纹、关节疼痛和痤疮。竞争格局和主要公司:光疗市场的主要参与者包括荷兰皇家飞利浦公司(Koninklijke Philips NV)、Beurer GmbH、BioPhotas、Northern Light Technologies、Lumie、Verilux公司、Zepter International、The Daylight Company、Zerigo Health和Naturebright。这些公司致力于扩大产品供应,以满足日益增长的全球消费者需求。他们的国际影响力使他们能够服务广泛的客户群,从而增加他们的市场份额。
The light therapy market is expected to increase from US$ 1.03 billion in 2024 to US$ 1.51 billion by 2031, with a projected CAGR of 5.6% during the period from 2025 to 2031.
Market Insights and Analyst Perspective:Light therapy, often referred to as phototherapy, involves the therapeutic application of specific light wavelengths to treat various conditions, including skin disorders, mood-related issues, and sleep disturbances. This non-invasive treatment method utilizes the distinct characteristics of light to provoke biological reactions in the body, primarily targeting the skin or retina, while also affecting circadian rhythms and mood-regulating systems. Light therapy can take various forms, such as blue light therapy for acne, red light therapy for skin rejuvenation, and bright light therapy for seasonal affective disorder.
Growth Drivers and Challenges:The increasing use of blue light therapy for skin conditions has become a key factor driving the growth and diversification of the light therapy market. Blue light therapy, a non-invasive phototherapy technique, has seen a rise in its application for treating various dermatological issues, including acne, psoriasis, eczema, and actinic keratosis. Its effectiveness in addressing specific skin problems, such as acne vulgaris, has garnered significant attention and acceptance from healthcare professionals and individuals seeking non-drug treatment alternatives. Technological advancements have further enhanced the use of blue light therapy, leading to the creation of specialized light delivery systems with optimized blue light wavelengths that specifically target and alleviate the root causes of skin conditions. The availability of home-use blue light therapy devices has also played a role in the market's growth, enabling individuals to conveniently manage their skin issues with user-friendly solutions.
Conversely, while light therapy provides numerous therapeutic advantages, the potential for side effects associated with certain methods has emerged as a challenge for the overall expansion of the light therapy market. Concerns about possible side effects, such as skin irritation, eye strain, and disruption of circadian rhythms, have raised caution among healthcare providers and potential users. These worries may discourage individuals from considering light therapy options, especially when there is a lack of information or guidance on safe and proper usage. Additionally, the necessity for precise dosimetry and adherence to treatment protocols, along with the risk of adverse reactions in sensitive individuals, poses a barrier to widespread acceptance. Addressing these risks through ongoing research, education, and the development of improved safety measures will be essential for overcoming these challenges and building greater confidence in the safety and efficacy of light therapy, thus promoting its broader use and contributing to market growth.
Strategic Insights
Report Segmentation and Scope:The light therapy market is categorized based on type, light type, application, and end user. By type, the market is divided into benchtop and portable categories. The light therapy market is segmented by light type into red, blue, and white light. In terms of application, the market is divided into mental health disorders, skin disorders, neonatal jaundice, and others. Regarding end users, the market is classified into hospitals and specialty clinics, homecare, and others. Geographically, the light therapy market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:In terms of type, the portable segment of the light therapy market is projected to experience the highest CAGR from 2022 to 2030. Portable light therapy devices have transformed the accessibility and convenience of light-based treatments, enabling individuals to receive therapeutic benefits while on the move. These portable solutions include a variety of devices, such as compact light boxes, wearable light visors, and handheld light wands, designed to provide targeted phototherapy in diverse environments. The portability of these devices allows users to easily incorporate light therapy into their daily lives, whether at home, in the office, or while traveling. Consequently, portable light therapy has broadened the reach of light-based treatments, giving individuals more control over their wellness routines and improving adherence to prescribed phototherapy regimens.
Regarding light type, the light therapy market is divided into red light, blue light, and white light. Red light therapy is expected to gain significant momentum in the coming years due to its ability to enhance mitochondrial function by facilitating biochemical reactions within cells. This results in increased production of adenosine triphosphate (ATP), which is claimed to support hair growth, promote wound healing, restore tissue, and reverse sun damage.
By application, the light therapy market is segmented into mental health disorders, skin disorders, neonatal care, and others. The skin disorder segment in hospitals dominated the market in 2022 and is expected to register a substantial CAGR during the forecast period. The effectiveness of light therapy in treating skin conditions such as acne, psoriasis, eczema, and dermatitis has driven its widespread adoption among healthcare professionals and individuals seeking non-pharmacological solutions. This segment has experienced notable growth due to advancing research that clarifies the photobiomodulatory effects of specific light wavelengths on skin cells and related biological processes.
Regional Analysis:Geographically, the light therapy market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
North America is the largest contributor to the growth of this market, driven by the increasing prevalence of psoriasis and symptoms of SAD/Winter blues; North America led the global light therapy market in 2022. Under medical supervision, light therapy involves exposing the skin to UV light from artificial sources. UVB and UVA light, or a combination of both, are utilized to alleviate symptoms, reduce inflammation, and control the proliferation of skin cells. The Canadian Dermatology Association estimates that one million Canadians suffer from psoriasis, which significantly drives the demand for light therapy devices. The Asia Pacific light therapy market is anticipated to record the fastest CAGR from 2022 to 2030, fueled by substantial investments in telemedicine and growing awareness of the benefits of light therapy.
Light Therapy Market Report ScopeIndustry Developments and Future Opportunities:Several initiatives undertaken by key players in the global light therapy market are highlighted below:
In September 2023, AMIRO, a prominent skincare and beauty technology provider, unveiled two of the year's most innovative products-the AMIRO S2 SEAL skin-tightening device and the AMIRO LumoMax LED light facial beauty device.
In June 2022, BioPhotas, Inc. formed a partnership with Ulta Beauty. This collaboration, utilizing the Celluma PRO and Celluma ELITE models, is expected to meet customers' skincare needs in 55 different locations across the US. These models have received FDA approval for treating various conditions, including wrinkles, joint pain, and acne.
Competitive Landscape and Key Companies:Major players in the light therapy market include Koninklijke Philips N.V.; Beurer GmbH; BioPhotas; Northern Light Technologies; Lumie; Verilux, Inc; Zepter International; The Daylight Company; Zerigo Health; and Naturebright. These companies are focused on expanding their product offerings to meet the growing global consumer demand. Their international presence enables them to serve a wide customer base, thereby allowing them to increase their market share.